Tandem Diabetes Care(TNDM)
$17.05-0.01 (-0.06%)
TNDM
Tandem Diabetes Care financials statements
$17.05
At close:-0.01 (-0.06%)
Want to see TNDM full AI Analyst Report?
Tandem Diabetes Care (TNDM) Ratios
1,481 Followers
Tandem Diabetes Care Ratios
TNDM's free cash flow for Q3 2026 was $-5.51M. For the 2026 fiscal year, TNDM's free cash flow was decreased by $-4.69M and operating cash flow was $-819.00K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.55 | 2.93 | 3.83 | 5.14 | 6.15 |
| Quick Ratio | 2.02 | 2.33 | 3.02 | 4.47 | 5.63 |
| Cash Ratio | 0.37 | 0.28 | 0.30 | 1.04 | 0.54 |
| Solvency Ratio | -0.26 | -0.14 | -0.32 | -0.13 | 0.06 |
| Operating Cash Flow Ratio | -0.04 | 0.10 | -0.16 | 0.31 | 0.84 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.60 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -107.80M | $ 19.93M | $ 108.96M | $ 237.14M | $ 339.50M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.50 | 0.49 | 0.44 | 0.40 | 0.35 |
| Debt-to-Equity Ratio | 2.86 | 1.80 | 1.33 | 0.95 | 0.73 |
| Debt-to-Capital Ratio | 0.74 | 0.64 | 0.57 | 0.49 | 0.42 |
| Long-Term Debt-to-Capital Ratio | 0.67 | 0.54 | 0.48 | 0.39 | 0.39 |
| Financial Leverage Ratio | 5.68 | 3.68 | 3.04 | 2.39 | 2.09 |
| Debt Service Coverage Ratio | -22.66 | -2.15 | -20.12 | -12.23 | 5.58 |
| Interest Coverage Ratio | -9.88 | -13.37 | -23.60 | -14.96 | 3.75 |
| Debt to Market Cap | 0.21 | 0.15 | 0.15 | 0.10 | 0.03 |
| Interest Debt Per Share | 6.72 | 7.35 | 6.56 | 6.64 | 5.09 |
| Net Debt to EBITDA | -2.03 | -4.08 | -1.82 | -3.33 | 7.15 |
| Profitability Margins | |||||
| Gross Profit Margin | 52.31% | 52.07% | 49.17% | 51.54% | 53.53% |
| EBIT Margin | -18.96% | -10.56% | -28.38% | -11.05% | 2.88% |
| EBITDA Margin | -17.22% | -10.54% | -26.27% | -9.26% | 4.85% |
| Operating Profit Margin | -7.70% | -10.54% | -31.19% | -11.59% | 3.22% |
| Pretax Profit Margin | -19.74% | -9.77% | -29.46% | -11.59% | 2.26% |
| Net Profit Margin | -20.17% | -10.21% | -29.77% | -11.81% | 2.21% |
| Continuous Operations Profit Margin | -20.17% | -10.21% | -29.77% | -11.81% | 2.21% |
| Net Income Per EBT | 102.22% | 104.52% | 101.07% | 101.88% | 97.89% |
| EBT Per EBIT | 256.36% | 92.68% | 94.44% | 100.00% | 70.19% |
| Return on Assets (ROA) | -23.23% | -9.92% | -23.37% | -8.99% | 1.72% |
| Return on Equity (ROE) | -131.93% | -36.50% | -70.98% | -21.50% | 3.59% |
| Return on Capital Employed (ROCE) | -12.24% | -13.76% | -30.79% | -10.46% | 2.93% |
| Return on Invested Capital (ROIC) | -11.88% | -12.72% | -30.12% | -10.31% | 2.83% |
| Return on Tangible Assets | -23.23% | -9.93% | -23.44% | -9.02% | 1.73% |
| Earnings Yield | -13.84% | -4.07% | -11.60% | -3.28% | 0.16% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.13 | 8.21 | 7.08 | 6.98 | 6.35 |
| Payables Turnover | 10.28 | 10.07 | 7.66 | 6.97 | 11.65 |
| Inventory Turnover | 3.76 | 3.01 | 2.41 | 3.49 | 4.76 |
| Fixed Asset Turnover | 5.65 | 5.75 | 4.55 | 4.47 | 9.02 |
| Asset Turnover | 1.15 | 0.97 | 0.78 | 0.76 | 0.78 |
| Working Capital Turnover Ratio | 2.38 | 1.83 | 1.21 | 1.17 | 1.16 |
| Cash Conversion Cycle | 121.16 | 129.44 | 155.59 | 104.33 | 102.79 |
| Days of Sales Outstanding | 59.53 | 44.48 | 51.53 | 52.26 | 57.51 |
| Days of Inventory Outstanding | 97.13 | 121.18 | 151.69 | 104.47 | 76.61 |
| Days of Payables Outstanding | 35.50 | 36.23 | 47.63 | 52.40 | 31.33 |
| Operating Cycle | 156.66 | 165.67 | 203.22 | 156.73 | 134.12 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.14 | 0.37 | -0.49 | 0.79 | 1.77 |
| Free Cash Flow Per Share | -0.44 | 0.08 | -0.90 | 0.26 | 1.39 |
| Dividend Paid and CapEx Coverage Ratio | -0.49 | 1.26 | -1.19 | 1.48 | 4.74 |
| Capital Expenditure Coverage Ratio | -0.49 | 1.26 | -1.19 | 1.48 | 4.74 |
| Operating Cash Flow Coverage Ratio | -0.02 | 0.05 | -0.08 | 0.12 | 0.35 |
| Operating Cash Flow to Sales Ratio | -0.01 | 0.03 | -0.04 | 0.06 | 0.16 |
| Free Cash Flow Yield | -2.01% | 0.21% | -3.05% | 0.57% | 0.93% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.23 | -24.50 | -8.62 | -30.48 | 609.20 |
| Price-to-Sales (P/S) Ratio | 1.46 | 2.51 | 2.57 | 3.60 | 13.49 |
| Price-to-Book (P/B) Ratio | 9.53 | 8.96 | 6.12 | 6.55 | 21.89 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -49.85 | 472.08 | -32.75 | 176.17 | 107.95 |
| Price-to-Operating Cash Flow Ratio | -152.14 | 97.32 | -60.35 | 57.14 | 85.15 |
| Price-to-Earnings Growth (PEG) Ratio | -0.07 | 0.43 | -0.06 | 0.04 | -4.21 |
| Enterprise Value Multiple | -10.49 | -27.86 | -11.59 | -42.19 | 285.57 |
| Enterprise Value | 1.83B | 2.76B | 2.28B | 3.13B | 9.73B |
| EV to EBITDA | -10.49 | -27.86 | -11.59 | -42.19 | 285.57 |
| EV to Sales | 1.81 | 2.94 | 3.04 | 3.91 | 13.84 |
| EV to Free Cash Flow | -61.77 | 553.04 | -38.84 | 191.28 | 110.72 |
| EV to Operating Cash Flow | -188.54 | 114.01 | -71.57 | 62.04 | 87.34 |
| Tangible Book Value Per Share | 2.31 | 4.01 | 4.79 | 6.79 | 6.77 |
| Shareholders’ Equity Per Share | 2.31 | 4.02 | 4.83 | 6.86 | 6.87 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.02 | -0.05 | -0.01 | -0.02 | 0.02 |
| Revenue Per Share | 15.08 | 14.36 | 11.52 | 12.49 | 11.16 |
| Net Income Per Share | -3.04 | -1.47 | -3.43 | -1.47 | 0.25 |
| Tax Burden | 1.02 | 1.05 | 1.01 | 1.02 | 0.98 |
| Interest Burden | 1.04 | 0.93 | 1.04 | 1.05 | 0.79 |
| Research & Development to Revenue | 0.17 | 0.21 | 0.33 | 0.21 | 0.13 |
| SG&A to Revenue | 0.43 | 0.41 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.09 | 0.11 | 0.12 | 0.11 | 0.09 |
| Income Quality | 0.05 | -0.25 | 0.14 | -0.53 | 7.15 |
Currency in USD

